17 November 2026
Sidley Represents RemeGen in Expanded US$356 Million Licensing Agreement With Vor Bio
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Lila Hope Lead | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Jiqiang (JQ) Lin Lead | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Joanna Wu | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Yuhan Wu | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Steven M. Przesmicki | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 356m (US$356 Million)
- What the figure measures
- Total transaction value
- Client
- RemeGen Co., Ltd.Sell-side
- Counterparties
- Vor Bio (Buy-side)